Antwort

Pneumologie 2008; 62 : 730 – 743

Literatur

• 1 Stolz D, Christ-Crain M, Gencay M M. et al . Diagnostic value of signs, symptoms and laboratory values in lower respiratory tract infection.  Swiss Med Wkly. 2006;  136 434-440
• 2 Muller B, Harbarth S, Stolz D. et al . Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia.  BMC Infect Dis. 2007;  7 10
• 3 van de Sande-Bruinsma N, Grundmann H, Verloo D. et al . Antimicrobial drug use and resistance in Europe.  Emerg Infect Dis. 2008;  14 1722-1730
• 4 Schwabe U, Paffrath D. Arzneiverordnungs-Report 2008; Aktuelle Daten, Kosten, Trends und Kommentare. Springer 2007
• 5 Burkhardt O, Evcuemen S, Wegscheider K. et al .Procalcitonin (PCT) in primary care patients with upper and lower respiratory tract infections (RTI). ATS Annual Conference 2008; 2008; Toronto, USA. 2008
• 6 Briel M, Schuetz P, Mueller B. et al . Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care.  Arch Intern Med. 2008;  168 2000-2007 [discussion 7 – 8]
• 7 Christ-Crain M, Stolz D, Bingisser R, Muller C. et al . Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial.  Am J Respir Crit Care Med. 2006;  174 84-93